BCEIE › News › AGARWALEYE

Management change

Dr. Agarwal's Health Care: Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as…

Dr. Agarwal's Health Care (AGARWALEYE) filed a disclosure titled "Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company". The company is valued…

BCEIE News Desk · Published 5 Nov 2026, 06:33 pm IST · Filing received 5 Nov 2026, 06:16 pm IST

What happened

Dr. Agarwal's Health Care (AGARWALEYE) filed a disclosure with the exchanges on 5 November 2026 at 06:16 PM titled "Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company".

Company snapshot

Dr. Agarwal's Health Care is a small-cap company in the Healthcare sector, with a market value of about ₹16,255 crore.

The stock last traded at ₹512.8, against a 52-week range of ₹401–₹567.8 (9.7% below the high).

Before this filing the shares had moved +5.4% over the month and +6.1% over three months. Average daily turnover over the last 20 sessions was about ₹10.62 crore.

Promoters held 32.34% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 57.96% and domestic institutions 7.72%.

Quarterly results (consolidated, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q1 FY2648730.10.95
Q2 FY2649929.70.94
Q3 FY2653033.71.07
Q4 FY2656439.71.25
Q1 FY2761445.21.43

What history shows

BCEIE's records show 1 previous management change filing from the company since May 2026.

Across 123 similar disclosures by other Healthcare companies, shares moved +1.1% on average the next day and +1.8% over five days; 50% of them rose the next day.

Market-wide, 4,282 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • The appointment of a successor and any change in strategy or guidance.
  • 5 November 2026: Board meeting — Financial Results.

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.

More on Dr. Agarwal's Health Care Limited